GREENBROOK TMS CONFIRMS RESIGNATION OF DIRECTOR
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
In accordance with Greenbrook's Majority Voting Policy, since Mr. Klein received more "withheld" votes than votes "for" at the Company's annual meeting of shareholders held on June 20, 2023, Mr. Klein has tendered his resignation as a director of the Company. After review and consideration, the Board has accepted Mr. Klein's resignation with immediate effect.
About Greenbrook TMS Inc.
Operating through 133 Company-operated treatment centers, Greenbrook is a leading provider of TMS and Spravato® (esketamine nasal spray), FDA-cleared, non-invasive therapies for the treatment of Major Depressive Disorder ("MDD") and other mental health disorders, in
View original content:https://www.prnewswire.com/news-releases/greenbrook-tms-confirms-resignation-of-director-301861195.html
SOURCE Greenbrook TMS Inc.